Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | TGM2 | P21980 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.57 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | PLAU | P00749 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.51 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL334749 | 0.98 | LMNA (0.69) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| (Chloromethyl)Benzene SCHEMBL28649859 | 0.92 | HTT (0.62) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL14486856 | 0.91 | HTT (0.64) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL15671941 | 0.91 | HTT (0.64) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL615296 | 0.90 | HTT (0.72) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL25132908 | 0.89 | PRSS1 (0.59) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL13055383 | 0.89 | LMNA (0.80) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| Hydrochloric Acid SCHEMBL616935 | 0.89 | HTT (0.70) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL335088 | 0.89 | HTT (0.70) | LMNASMN1; SMN2HTTTGM2SLC1A3 | |
| SCHEMBL4363476 | 0.87 | HTT (0.68) | LMNASMN1; SMN2HTTTGM2SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 691 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025118255-A1 | RADIOLABELED FAPI COMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | 北京师范大学 | 2025-06-12 | — | — | WO | claimed |
| CN-119604492-A | Radiolabeled FAPI complex and preparation method and application thereof | 北京师范大学 | 2025-03-11 | — | — | CN | claimed |
| CN-116023643-A | Acid-sensitive polymer containing beta-carboxyl amide bond, and preparation method and application thereof | 复旦大学 | 2023-04-28 | — | — | CN | claimed |
| CN-114377142-A | ROS-responsive prodrug realizing deep delivery by pH response and step-by-step targeting | 宁波大学 | 2022-04-22 | — | — | CN | claimed |
| CN-104557704-B | Preparation method of pixantrone maleate | 北京凯莱天成医药科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| US-5602161-A | ELASTASE INHIBITORS; PREVENTING AND TREATING EMPHYSEMA, ENDOTOXIN-INDUCED LUNG DISORDERS | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1997-02-11 | — | — | US | claimed |
| EP-0676396-A1 | Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1995-10-11 | — | — | EP | claimed |
| EP-4745237-A1 | RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF | YUN HO BIO CO., LTD (CN) | 2026-05-20 | — | — | EP | disclosed |
| EP-4739345-A1 | BORONATED HYDROGELS AND METHODS OF MAKING AND USING THE SAME | Boston Scientific Scimed, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4725560-A2 | ANTI-B7H3 ANTIBODIES FOR THE PREPARATION OF ANTIBODY DRUG CONJUGATES (ADCS) OF KSP INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2026-04-15 | — | — | EP | disclosed |
| US-20260091081-A1 | A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-04-02 | — | — | US | disclosed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | disclosed |
| US-20260061065-A1 | ANTIBODY DRUG CONJUGATES | NOVARTIS AG (CH) | 2026-03-05 | — | — | US | disclosed |
| WO-1983003828-A1 | 1-CARBOXYALKANOYLPERHYDROINDOLE-2-CARBOXYLIC ACIDS AND DERIVATIVES | CIBA-GEIGY AG (CH) | 1983-11-10 | — | — | WO | disclosed |
| EP-0013147-B1 | POLYMERISABLE MONOMERS, THEIR USE TO PREPARE CROSS-LINKABLE POLYMERS AND THE CROSS-LINKABLE POLYMERS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-10-26 | — | — | EP | disclosed |
| US-4346231-A | Polymerizable ethylenically unsaturated amide compounds | PONTICELLO IGNAZIO S | 1982-08-24 | — | — | US | disclosed |
| US-4247673-A | COLOR COUPLERS, PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1981-01-27 | — | — | US | disclosed |
| US-4215195-A | CROSSLINKABLE, POLYMERIC COLOR COUPLERS, GELATIN EXTENDERS, BINDERS | EASTMAN KODAK COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
| EP-0013147-A2 | POLYMERISABLE MONOMERS, THEIR USE TO PREPARE CROSS-LINKABLE POLYMERS AND THE CROSS-LINKABLE POLYMERS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1980-07-09 | — | — | EP | disclosed |
| US-4178371-A | ANALGESIC, NARCOTIC ANTAGONIST OR ANTIDIARRHEAL AGENT | RECKITT & COLMAN PRODUCTS LIMITED (GB) | 1979-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | CD4, TAP1, MCTS1 | LMNA 2109/4885SMN1; SMN2 1758/4885HTT 1768/4885 |
| US-20260061065-A1 | ANTIBODY DRUG CONJUGATES | FCGR2A, FCGR3B, BCL3 | LMNA 254/4885SMN1; SMN2 1063/4885HTT 2649/4885 |
| US-20260091081-A1 | A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE | CD4, MALT1, LY6K | LMNA 2507/4885SMN1; SMN2 3725/4885HTT 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.